Baxter International | BAX - Loan Capital

Stock Price
16.52
Daily Change
-0.14 -0.84%
Monthly
-22.30%
Yearly
-50.23%
Q1 Forecast
16.87

Baxter International reported $9.47B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 217.81M 2.94M Dec/2025
AtriCure USD 61.86M 0 Dec/2025
Avanos Medical USD 90.3M 3.1M Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 10.99B 12M Sep/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Globus Medical USD 436K 9K Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
ICU Medical USD 1.27B 48.01M Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 39.44B 30M Dec/2025
Laboratory Of America USD 5.15B 800K Dec/2025
Masimo USD 518M 41.1M Dec/2025
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Quest Diagnostics USD 5.17B 4M Dec/2025
Smith & Nephew USD 3.3B 22M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Terumo JPY 99.9B 12M Dec/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025